Phase 2 Precursor B-Cell Lymphoblastic Leukemia Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Peking University People's Hospital50 enrolled1 locationNCT06880913

Recruiting

Phase 2

Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL

Precursor B-Cell Lymphoblastic Leukemia

First Affiliated Hospital of Zhejiang University20 enrolled1 locationNCT06554626